Search
Altimmune Inc
ALTAdd to Watchlist
3.040USD
-0.150-4.70%
Close 09-24 16:00（ET）
591.19MMarket Cap
LossP/E TTM
After-hours 19:45 (ET)3.060USD+0.015+0.49%
After-hours 19:45 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-4.70%
5 Days
-6.17%
1 Month
-2.25%
6 Months
-6.17%
Year to Date
-15.79%
1 Year
-22.45%
Key Figures
3.180Open
3.425High
354.42KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.18%Turnover Ratio
3.190Prev. Close
2.985Low
1.09MTurnover
LossP/E Static
1.25P/B
0.00%Div Yield TTM
-36.96%ROA
6.44052wk High
24.96Volume Ratio
-95.06MNet Profit
194.47MShares
-0.9220EPS TTM
0.20Beta
-42.75%ROE
2.56052wk Low
13.79%Amplitude
100.00%Gross Margin
591.19MMarket Cap
1.26Reward/Risk
4.33%Risk Rate
Altimmune Inc's Score
-0.07vs previous score
Forecast8.36
Financial Health7.07
Technical3.55
Valuation Dimensions6.97
Institutional Confidence3.00
Risk Assessment5.23
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Altimmune Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Altimmune Inc Latest Earnings Call Transcripts
Altimmune (ALT) Q2 2026 Earnings Call: PERFORMA Starts, Cash Reaches $519M
Altimmune Q2 2026 earnings call: PERFORMA Phase III enrollment begins, RECLAIM AUD data support pivotal planning, and cash reaches $519 million.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.12/-0.14
Revenue / Forecast
0.00/0.00
Altimmune Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolALT
Number of employees59
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Deep Track Capital LP | 9.91% |
| BlackRock Institutional Trust Company, N.A. | 4.04% |
| State Street Investment Management (US) | 3.68% |
| Viking Global Investors LP | 3.45% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 18.22% |
| Hedge Fund | 14.76% |
| Investment Advisor/Hedge Fund | 11.03% |
| Venture Capital | 3.35% |
Related Instruments
+2.68%
+0.56%
+0.02%
-0.07%
+0.60%
+0.75%
-0.01%
-1.11%
+1.18%
+0.82%
+1.17%
+0.57%
-1.27%
-0.12%
-1.73%
-0.72%
+6.98%
+1.73%
-1.17%
+0.61%
FAQs
What is the current price of Altimmune Inc (ALT)?
The current price of Altimmune Inc (ALT) is 3.04.
What is the symbol of Altimmune Inc?
The ticker symbol of Altimmune Inc is ALT.
What is the 52-week high of Altimmune Inc?
The 52-week high of Altimmune Inc is 6.44.
What is the 52-week low of Altimmune Inc?
The 52-week low of Altimmune Inc is 2.56.
What is the market capitalization of Altimmune Inc?
The market capitalization of Altimmune Inc is 591.19M.
Is Altimmune Inc (ALT) currently rated as Buy, Hold, or Sell?
According to analysts, Altimmune Inc (ALT) has an overall rating of Buy, with a price target of 17.11.
What is the Earnings Per Share (EPS TTM) of Altimmune Inc (ALT)?
The Earnings Per Share (EPS TTM) of Altimmune Inc (ALT) is -0.92.